ON-Q/ambIT Pumps (NOPAIN Act)
Post-Surgical Pain Management
Key Facts
About Avanos Medical
Avanos Medical is a publicly traded medical device company with a dual focus on Pain Management & Recovery and Enteral Feeding. A key strategic achievement is the inclusion of its ON-Q and ambIT infusion pumps under the new CMS reimbursement rules from the NOPAIN Act, effective January 2025, which validates its non-opioid approach and creates a significant market catalyst. The company's strategy leverages its established global commercial footprint, a portfolio of trusted brands, and targeted innovation to address the opioid crisis and the critical need for reliable nutritional support across care settings.
View full company profileTherapeutic Areas
Other Post-Surgical Pain Management Drugs
| Drug | Company | Phase |
|---|---|---|
| Ropivacaine Readyfusor | BioQ Pharma | Approved |
| TPU-006 | Teikoku Pharma | Phase 2 |